We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC DEPAKOTE GETS APPROVABLE LETTER FROM FDA
GENERIC DEPAKOTE GETS APPROVABLE LETTER FROM FDA
January 16, 2004
Generic firm Andrx announced it has received conditional approval from the FDA for its new mania and seizure treatment valproate delayed-release tablets, which is similar to brand firm Abbott Laboratories’ profitable drug Depakote.